Menu

Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment

by MedAccess, Viatris and TB Alliance

Subscribe to our newsletter

Receive regular updates about how our innovative finance work is making healthcare products more affordable and accessible.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Close